Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Total Liabilities (2019 - 2025)

Historic Total Liabilities for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to $312.6 million.

  • CureVac's Total Liabilities rose 11980.86% to $312.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $312.6 million, marking a year-over-year increase of 11980.86%. This contributed to the annual value of $113.5 million for FY2024, which is 6111.65% down from last year.
  • Per CureVac's latest filing, its Total Liabilities stood at $312.6 million for Q3 2025, which was up 11980.86% from $116.0 million recorded in Q2 2025.
  • CureVac's Total Liabilities' 5-year high stood at $1.2 billion during Q2 2021, with a 5-year trough of $100.5 million in Q1 2025.
  • Its 5-year average for Total Liabilities is $362.8 million, with a median of $283.6 million in 2023.
  • Per our database at Business Quant, CureVac's Total Liabilities tumbled by 9962.5% in 2021 and then skyrocketed by 11980.86% in 2025.
  • CureVac's Total Liabilities (Quarter) stood at $537.4 million in 2021, then tumbled by 37.88% to $333.8 million in 2022, then fell by 12.56% to $291.9 million in 2023, then tumbled by 61.12% to $113.5 million in 2024, then soared by 175.4% to $312.6 million in 2025.
  • Its Total Liabilities was $312.6 million in Q3 2025, compared to $116.0 million in Q2 2025 and $100.5 million in Q1 2025.